edoc

Items where contributor is "Ladanie, Aviv"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: Article

Article

Ladanie, Aviv and Schmitt, Andreas M. and Speich, Benjamin and Naudet, Florian and Agarwal, Arnav and Pereira, Tiago V. and Sclafani, Francesco and Herbrand, Amanda K. and Briel, Matthias and Martin-Liberal, Juan and Schmid, Thomas and Ewald, Hannah and Ioannidis, John P. A. and Bucher, Heiner C. and Kasenda, Benjamin and Hemkens, Lars G.. (2020) Clinical trial evidence supporting US Food and Drug Administration approval of novel cancer therapies between 2000 and 2016. Jama Network Open, 3 (11). e2024406.

Mc Cord, Kimberly A. and Ewald, Hannah and Ladanie, Aviv and Briel, Matthias and Speich, Benjamin and Bucher, Heiner C. and Hemkens, Lars G. and RCD for RCTs initiative and the Making Randomized Trials More Af, . (2019) Current use and costs of electronic health records for clinical trial research : a descriptive study. CMAJ open, 7 (1). E23-E32.

Ewald, Hannah and Speich, Benjamin and Ladanie, Aviv and Bucher, Heiner C. and Ioannidis, John P. A. and Hemkens, Lars G.. (2019) Marginal structural models and other analyses allow multiple estimates of treatment effects in randomized clinical trials: Meta-epidemiological analysis. Journal of clinical epidemiology, 107. pp. 12-26.

Ladanie, Aviv and Speich, Benjamin and Briel, Matthias and Sclafani, Francesco and Bucher, Heiner C. and Agarwal, Arnav and Ioannidis, John P. A. and Pereira, Tiago V. and Kasenda, Benjamin and Hemkens, Lars G.. (2019) Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies. Journal of clinical epidemiology, 114. pp. 49-59.

Ewald, Hannah and Ioannidis, John P. A. and Ladanie, Aviv and Mc Cord, Kimberly and Bucher, Heiner C. and Hemkens, Lars G.. (2019) Nonrandomized studies using causal-modeling may give different answers than RCTs: a meta-epidemiological study. Journal of clinical epidemiology, 118. pp. 29-41.

Ladanie, Aviv and Ioannidis, John P. A. and Stafford, Randall S. and Ewald, Hannah and Bucher, Heiner C. and Hemkens, Lars G.. (2018) Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials. Journal of clinical epidemiology, 94. pp. 35-45.

Ladanie, Aviv and Speich, Benjamin and Naudet, Florian and Agarwal, Arnav and Pereira, Tiago V. and Sclafani, Francesco and Martin-Liberal, Juan and Schmid, Thomas and Ewald, Hannah and Ioannidis, John P. A. and Bucher, Heiner C. and Kasenda, Benjamin and Hemkens, Lars G.. (2018) The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: rationale and design of the database and the collection of evidence available at approval of novel drugs. Trials, 19 (1). p. 505.

Ladanie, Aviv and Ewald, Hannah and Kasenda, Benjamin and Hemkens, Lars G.. (2018) How to use FDA drug approval documents for evidence syntheses. BMJ, 362. k2815.

Ladanie, Aviv and Ioannidis, John P. A. and Stafford, Randall S. and Ewald, Hannah and Bucher, Heiner C. and Hemkens, Lars G. and Hemkens, Lars G.. (2018) Off-label prescription : experience is a gloomy lantern that does not even illuminate its bearer. Journal of clinical epidemiology, 101. pp. 127-128.